Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
about
Kallikrein-kinin in stem cell therapyBlockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.Cyclic nucleotide signalling in kidney fibrosis.Hypertension and impaired renal function accompany juvenile obesity: the effect of prenatal diet.The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.Intermedin ameliorates vascular and renal injury by inhibition of oxidative stressContribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats.A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development ConceptRole of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury.Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats.Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).Blockade of Bradykinin receptors worsens the dystrophic phenotype of mdx mice: differential effects for B1 and B2 receptors.
P2860
Q27010386-E9D949DD-28C5-4D4F-A8C2-8C599D5C31E0Q33783946-FC4E2EE0-BB31-4D98-B036-93572BF9CED9Q34289034-9E5B327B-A736-4597-B1B0-954A8F555AC1Q35138860-9E50A21D-4326-495F-8807-796D4C9BF06BQ36088422-ACD6A97F-81DC-4CDF-9AAE-7CC1AE6DF5B6Q36519364-BDBB284B-D8C4-464C-8EF0-E617DBF7D783Q37018402-1F48183D-ED66-4EA0-9331-6ED09AB14A9EQ37151470-F695D636-8929-4104-8B03-5FD888E50C9AQ37709440-CECED8D6-B089-4E57-947F-B592BF99A541Q40019674-24369BC1-2376-4A53-A7C5-D7E34425F7E6Q46179217-0B066DE8-8EF5-4674-AAC5-BBBC951424F7Q47554530-8451DC22-6EBF-4B3B-9747-1ED253538396Q47776900-87B1BB26-93FD-455E-AB21-4D8069EB40C6
P2860
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@en
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@nl
type
label
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@en
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@nl
prefLabel
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@en
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@nl
P2093
P2860
P1476
Kallikrein gene transfer reduc ...... n DOCA-salt hypertensive rats.
@en
P2093
Chun-Fang Xia
Grant Bledsoe
Julie Chao
P2860
P304
P356
10.1152/AJPRENAL.00427.2004
P577
2005-05-10T00:00:00Z